Skip to main content
. 2017 Aug 22;216(8):1008–1017. doi: 10.1093/infdis/jix421

Figure 3.

Figure 3.

Impact of dosing frequency and recent use of dihydroartemisinin-piperaquine (DP) on the prevalence of wild-type, mixed, or mutant alleles at Plasmodium falciparum loci of interest in parasitemic samples. A, Allele prevalences in parasites from patients receiving DP every 8 weeks (DP8w) or every 4 weeks (DP4w). B, Allele prevalences in parasites from patients who received DP 29–56 days or 4–28 days before parasitemic episodes.